Recent Finacing
Recent Raise
Jaguar Gene Therapy develops AAV9-based, preclinical gene therapies (JAG101, JAG201, JAG301) and operates in-house CMC and commercially scalable AAV manufacturing to support IND-enabling studies.
Focus Areas
Recent Investors
Total Raised
Funding rounds
Investors
See the team members at Jaguar Gene Therapy.
